Recent news on Mecamylamine Hydrochloride

Targacept Reports First Quarter 2007 Financial Results  -  May 9, 2007
PR-Inside.com (Pressemitteilung),Conducted additional preclinical testing and pharmaceutical development of TC-5214, an enantiomer of mecamylamine hydrochloride that the company expects

Targacept Reports Fourth Quarter and 2006 Financial Results  -  Feb 28, 2007
Drug Newswire (press release),...the position of applicable regulatory authorities with regard to a treatment combination that includes mecamylamine hydrochloride, which is a racemate,

Targacept Reports Fourth Quarter and 2006 Financial Results  -  Feb 22, 2007
MSN MoneyAnnounced positive top line results of the Phase II clinical trial of mecamylamine hydrochloride as an augmentation therapy to citalopram hydrobromide,

Targacept Initiates Phase I Clinical Trial of TC-2216  -  Jan 9, 2007
Drug Newswire (press release),Mecamylamine hydrochloride binds non-selectively to various NNR subtypes, but there is a body of scientific evidence that suggests that its anti-depressant

Targacept Releases Antidepressant Data  09 Nov 2006
II clinical trial, patients who did not respond to Forest Laboratories (nyse: FRX - news - people )' Celexa were given mecamylamine hydrochloride along with ... -Forbes, Targacept Reports Second Quarter 2006 Financial Results  Aug 9, 2006
Completed the dosing phase of Targacept's ongoing Phase II trial of mecamylamine hydrochloride as an add-on therapy for depression in August. ... -PR Newswire

Targacept to Report Second Quarter 2006 Financial Results on ...  Aug 2, 2006
Targacept has a marketed product, Inversine(R) (mecamylamine hydrochloride), product candidates in development for Alzheimer's disease and cognitive deficits ... -PR Newswire

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional